Latest Insider Transactions at Erasca, Inc. (ERAS)
This section provides a real-time view of insider transactions for Erasca, Inc. (ERAS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Erasca, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Erasca, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2024
|
Alexander W. Casdin Director |
BUY
Open market or private purchase
|
Direct |
80,000
+12.23%
|
$160,000
$2.27 P/Share
|
|
Dec 15
2023
|
David M. Chacko CFO and CBO |
BUY
Other acquisition or disposition
|
Direct |
7,478
+2.94%
|
$7,478
$1.59 P/Share
|
|
Dec 15
2023
|
Ebun Garner General Counsel & Corp. Sec. |
BUY
Other acquisition or disposition
|
Direct |
5,448
+35.9%
|
$5,448
$1.59 P/Share
|
|
Dec 06
2023
|
Valerie Denise Harding Start Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+33.33%
|
$10,000
$1.85 P/Share
|
|
Dec 06
2023
|
Jonathan E Lim Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
278,150
+2.11%
|
$278,150
$1.72 P/Share
|
|
Dec 05
2023
|
Jonathan E Lim Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
721,850
+5.3%
|
$721,850
$1.69 P/Share
|
|
Dec 04
2023
|
Alexander W. Casdin Director |
BUY
Open market or private purchase
|
Direct |
30,000
+5.73%
|
$30,000
$1.66 P/Share
|
|
Oct 05
2023
|
Jonathan E Lim Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+4.89%
|
$2,000,000
$2.03 P/Share
|
|
Jun 08
2023
|
Jonathan E Lim Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.54%
|
$200,000
$2.75 P/Share
|
|
Apr 10
2023
|
Alexander W. Casdin Director |
BUY
Open market or private purchase
|
Direct |
20,000
+4.13%
|
$40,000
$2.76 P/Share
|
|
Mar 28
2023
|
Jonathan E Lim Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.54%
|
$200,000
$2.84 P/Share
|
|
Feb 01
2023
|
David M. Chacko CFO and CBO |
BUY
Other acquisition or disposition
|
Direct |
1,750
+0.36%
|
$5,250
$4.0 P/Share
|
|
Feb 01
2023
|
Ebun Garner General Counsel & Corp. Sec. |
BUY
Other acquisition or disposition
|
Direct |
2,390
+17.93%
|
$7,170
$4.0 P/Share
|
|
Feb 01
2023
|
Lin Wei Chief Medical Officer |
BUY
Other acquisition or disposition
|
Direct |
1,750
+0.28%
|
$5,250
$4.0 P/Share
|
|
Jan 10
2023
|
Jonathan E Lim Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
60,000
+0.3%
|
$180,000
$3.86 P/Share
|
|
Dec 21
2022
|
James Arthur Bristol Director |
BUY
Open market or private purchase
|
Indirect |
20,000
+50.0%
|
$80,000
$4.14 P/Share
|
|
Dec 21
2022
|
Valerie Denise Harding Start Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$40,000
$4.64 P/Share
|
|
Dec 15
2022
|
Alexander W. Casdin Director |
BUY
Open market or private purchase
|
Direct |
20,000
+4.31%
|
$80,000
$4.87 P/Share
|
|
Dec 14
2022
|
Jonathan E Lim Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
40,000
+0.2%
|
$160,000
$4.99 P/Share
|
|
Dec 13
2022
|
Bihua Chen |
BUY
Open market or private purchase
|
Indirect |
307,692
+2.77%
|
$1,846,152
$6.5 P/Share
|
|
Jul 01
2022
|
Alexander W. Casdin Director |
SELL
Other acquisition or disposition
|
Indirect |
750,000
-100.0%
|
-
|
|
Feb 01
2022
|
David M. Chacko CFO and CBO |
BUY
Other acquisition or disposition
|
Direct |
1,562
+0.65%
|
$17,182
$11.6 P/Share
|
|
Feb 01
2022
|
Lin Wei Chief Medical Officer |
BUY
Other acquisition or disposition
|
Direct |
1,562
+0.49%
|
$17,182
$11.6 P/Share
|
|
Feb 01
2022
|
Ebun Garner General Counsel & Corp. Sec. |
BUY
Other acquisition or disposition
|
Direct |
990
+34.38%
|
$10,890
$11.6 P/Share
|
|
Aug 10
2021
|
Bihua Chen |
BUY
Open market or private purchase
|
Indirect |
200,000
+1.87%
|
$4,400,000
$22.1 P/Share
|
|
Jul 26
2021
|
Bihua Chen |
SELL
Open market or private sale
|
Indirect |
200,000
-1.9%
|
$3,600,000
$18.77 P/Share
|
|
Jul 20
2021
|
Bihua Chen |
BUY
Open market or private purchase
|
Indirect |
950,000
+8.29%
|
$15,200,000
$16.0 P/Share
|
|
Jul 20
2021
|
Bihua Chen |
BUY
Conversion of derivative security
|
Indirect |
9,555,553
+50.0%
|
-
|
|
Jul 20
2021
|
Julie Hambleton Director |
BUY
Open market or private purchase
|
Direct |
6,000
+50.0%
|
$96,000
$16.0 P/Share
|
|
Jul 20
2021
|
Pratik S Multani Director |
BUY
Open market or private purchase
|
Direct |
6,200
+3.46%
|
$99,200
$16.0 P/Share
|
|
Jul 20
2021
|
Valerie Denise Harding Start Director |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$32,000
$16.0 P/Share
|
|
Jul 20
2021
|
Arch Venture Partners X, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
11,055,554
+50.0%
|
-
|
|
Jul 20
2021
|
Alexander W. Casdin Director |
BUY
Conversion of derivative security
|
Indirect |
750,000
+50.0%
|
-
|
|
Jul 20
2021
|
Alexander W. Casdin Director |
BUY
Conversion of derivative security
|
Direct |
150,000
+30.77%
|
-
|
|
Jul 20
2021
|
Ebun Garner General Counsel & Corp. Sec. |
BUY
Open market or private purchase
|
Direct |
900
+50.0%
|
$14,400
$16.0 P/Share
|
|
Jul 20
2021
|
Jonathan E Lim Chairman & CEO |
BUY
Conversion of derivative security
|
Indirect |
10,576,417
+25.84%
|
-
|